WASHINGTON (Legal Newsline) — The Federal Trade Commission (FTC) announced Dec. 19 it has approved an application by Fresenius Medical Care AG & Co. KGaA, allowing the company to establish a new outpatient clinic in a location where it previously divested a clinic.
On Feb. 28, 2012, Fresenius sold 60 dialysis clinics throughout the United States after a settlement with the FTC. After the divestiture, Fresenius was allowed to complete its acquisition of Liberty Dialysis Holdings Inc. As per the agreement, however, Fresenius could not reacquire any interest in the clinics it divested unless it received FTC approval.
Fresenius can establish a new clinic in Wyoming, Michigan—a location involved in the previous settlement.
The FTC voted 2-0 to approve the application. Eric D. Rohlck of the Bureau of Competition is the staff contact for the case.